Related Experiment Videos
Recipient selection and management before cardiac transplantation
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA.
The American Journal of the Medical Sciences
|September 23, 1997
Summary
Cardiac transplantation effectively treats end-stage congestive heart failure. Careful recipient selection is crucial due to donor scarcity, prioritizing patients with limited survival and quality of life for long-term benefit.
Area of Science:
- Cardiology
- Transplant Surgery
Background:
- Congestive heart failure (CHF) is a leading cause of mortality.
- Cardiac transplantation is an established therapy for end-stage CHF.
- Limited donor organ availability poses a significant challenge.
Purpose of the Study:
- To outline recipient selection criteria for cardiac transplantation.
- To emphasize the importance of multidisciplinary assessment.
- To discuss evolving strategies in light of donor organ scarcity.
Main Methods:
- Multidisciplinary team evaluation (transplant physicians and surgeons).
- Assessment of cardiac dysfunction severity and patient prognosis.
- Risk stratification for mortality.
Main Results:
- Candidates are patients with severely limited survival and quality of life without transplantation.
- Careful screening identifies patients likely to achieve long-term benefit.
- Evolving criteria address extended waiting times and high mortality.
Conclusions:
- Recipient selection is critical for optimizing outcomes in cardiac transplantation.
- Strategies must adapt to donor organ shortages and patient survival rates.
- Alternative therapies should be considered when appropriate.